Using neoadjuvant therapy response to guide adjuvant therapy in HER2+breast cancer

被引：0
|
作者：
Krop, I. [1 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BREAST | 2019年 / 44卷
关键词：
D O I：
10.1016/S0960-9776(19)30099-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SA 10.2
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] The Pathological Response of Her2+Breast Cancer with Neoadjuvant Chemotherapy and Radiation Therapy
    Chao, M.
    Baker, C.
    Jassal, S.
    Law, M.
    Bevington, E.
    Stoney, D.
    Zantuck, N.
    Chew, G.
    Loh, S. W.
    Hyett, A.
    Guerrieri, M.
    Ng, M.
    Cokelek, M.
    Neoh, D.
    Yong, C.
    Ho, H.
    Tacey, M.
    Joon, D. Lim
    Khor, R.
    Foroudi, F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E17 - E17
  • [2] Adjuvant therapy for HER2+breast cancer: practice, perception, and toxicity
    Rocque, Gabrielle
    Onitilo, Adedayo
    Engel, Jessica
    Pettke, Erica
    Boshoven, Alice
    Kim, KyungMann
    Rishi, Shailly
    Waack, Bonnie
    Wisinski, Kari B.
    Tevaarwerk, Amye
    Burkard, Mark E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 713 - 721
  • [3] Adjuvant and neoadjuvant trastuzumab in combination with vinorelbine for HER2+breast cancer.
    Esfahani, Khashayar
    Ferrario, Cristiano
    Le, Philippe
    Panasci, Lawrence C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Identification of UGT2B15 as a potential biomarker in response to neoadjuvant therapy in HER2+breast cancer
    Gil-Torralvo, Ana
    Benavent, Marta
    Dominguez-Cejudo, Maria A.
    Falcon, Alejandro
    Vieites, Begona
    Molina-Pinela, Sonia
    Ruiz, Manuel
    Montano, Alvaro
    Gonzalez, Rosario
    Martinez, Julia
    de la Haba, Juan
    Rodriguez, Antonio
    Queipo, Maria I.
    Jimenez, Begona
    Salvador-Bofill, Javier
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [5] A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+breast cancer
    Esposito, Angela
    Viale, Giulia
    Criscitiello, Carmen
    Curigliano, Giuseppe
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (01) : 9 - 16
  • [6] Integration of metabolomics and transcriptomics to Reveal Potential Biomarkers Associated with Treatment Response of Neoadjuvant Therapy in HER2+Breast Cancer
    Zhang, Ningning
    Huang, Yuxin
    Wang, Guanwen
    Xiang, Yimei
    Jing, Zhouhong
    Zeng, Junjie
    Yu, Feng
    Pan, Xianjun
    Zhou, Wenqi
    Zeng, Xiaohua
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [7] Integration of metabolomics and transcriptomics to reveal potential biomarkers associated with treatment response of neoadjuvant therapy in HER2+breast cancer
    Zhang, N.
    Xiang, Y.
    Jing, Z.
    Yu, F.
    Zeng, J.
    Pan, X.
    Zhou, W.
    Liang, X.
    Yue, Y.
    Zhang, H.
    Deng, Y.
    Deng, S.
    Mo, S.
    Jiang, X.
    Zeng, X.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S249 - S249
  • [8] Identification of UGT2B family genes as potential biomarkers of response to neoadjuvant therapy in HER2+breast cancer
    Gil-Torralvo, Ana
    Benavent, Marta
    Dominguez-Cejudo, Maria A.
    Falcon, Alejandro
    Cejuela, Monica
    Vieites, Begona
    Molina-Pinelo, Sonia
    Borrego, Manuel Ruiz
    de la Haba-Rodriguez, Juan
    Queipo, Maria I.
    Bofill, Francisco Javier Salvador
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [9] FDG PET/CT for early prediction of response to neoadjuvant therapy in HER2+breast cancer: validation in a multicentric population
    Tisserand, S.
    Kanoun, S.
    Blanc, J.
    Coudert, B.
    Berriolo-Riedinger, A.
    Cachin, F.
    Champion, L.
    Humbert, O.
    Salaun, P.
    Mognetti, T.
    Kerrou, K.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S305 - S306
  • [10] Tumor Infiltrating Lymphocytes (TIL) in Predicting Neoadjuvant Therapy Response and Survival in HER2+Breast Cancers
    Andrews, Caitlin
    Mittendorf, Elizabeth A.
    Song, Juhee
    Hunt, Kelly K.
    Sahin, Aysegul A.
    Wu, Yun
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 29A - 29A
12345